Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancer. - An,J.; Sun,Y.P.; Adams,J.; Fisher,M.; Belldegrun,A.; Rettig,M.B. (Clin Cancer Res, 2003)